PacBio Announces Preliminary Fourth Quarter and Full Year Revenue

1 day ago · MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced …

$39
OFF

PacBio Announces Preliminary Q4 Revenue Of $39.2M - MSN

2 weeks from now

PacBio (NASDAQ:PACB) on Tuesday announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154 million, representing a year-over …

msn.com

$39
OFF

PacBio Announces Preliminary Q4 Revenue Of $39.2M

2 weeks from now

19 hours ago · PacBio (NASDAQ:PACB) on Tuesday announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154 million, representing …

seekingalpha.com

$39
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

18 hours ago · Preliminary, unaudited revenue for the fourth quarter of 2024 is expected to be approximately $39.2 million compared with $58.4 million in the prior-year period.

businessinsider.com

$18
OFF

PacBio Announces Record Preliminary Fourth Quarter And Full Year ...

2 weeks from now

Jan 8, 2024 · Ships a record number of PacBio sequencers in 2023, including 173 Revio™ systems, and announces record fourth quarter preliminary consumable revenue of $18.9 …

marketscreener.com

$16
OFF

PacBio Announces Record Preliminary Fourth Quarter 2021 …

2 weeks from now

Jan 11, 2022 · Preliminary instrument revenue for the fourth quarter of 2021 is expected to be approximately $16.2 million, compared with $15.9 million for the third quarter of 2021, and …

yahoo.com

$39
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year

2 weeks from now

19 hours ago · Preliminary, unaudited revenue for the fourth quarter of 2024 is expected to be approximately $39.2 million compared with $58.4 million in the prior-year period.

globenewswire.com

113%
OFF

PacBio Reports Record Prelim Q4 And Full Year Revenue

2 weeks from now

Jan 8, 2024 · pacific biosciences of california inc pacb: pacbio announces record preliminary fourth quarter and full year revenue growing 113% and 56%, respectively. pacific biosciences …

tradingview.com

$15
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

15 hours ago · Preliminary instrument revenue for the fourth quarter of 2024 is expected to be approximately $15.3 million, compared with $35.1 million for the fourth quarter of 2023.

finanznachrichten.de

33%
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

1 day ago · The preliminary Q4 results reveal concerning trends for PacBio, with revenue declining 33% year-over-year to $39.2 million.Most notably, instrument revenue dropped …

stocktitan.net

31%
OFF

BioLife Solutions Announces Preliminary Fourth Quarter And Full …

2 weeks from now

1 day ago · Preliminary and unaudited revenue for continuing operations for the fourth quarter of 2024 was $22.7 million, an increase of 31% from $17.4 million for the fourth quarter of 2023.

yahoo.com

FAQs about PacBio Announces Preliminary Fourth Quarter and Full Year Revenue Coupon?

How did PacBio perform in Q4 2024?

MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a year-over-year decline of 33% and 23%, respectively. ...

What was PacBio's fourth quarter revenue?

PacBio reported preliminary, unaudited revenue of approximately $58.4 million for its fourth quarter ended December 31, 2023. Preliminary instrument revenue for the fourth quarter of 2023 is expected to be approximately $35.1 million, compared with $6.1 million for the fourth quarter of 2022. ...

How much did PacBio make in Q4 2022?

MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue of approximately $36.0 million for its fourth quarter ended December 31, 2021. ...

How many PacBio sequencers were shipped in 2023?

Ships a record number of PacBio sequencers in 2023, including 173 Revio™ systems, and announces record fourth quarter preliminary consumable revenue of $18.9 million as demand for long-read sequencing grows and increased capacity from the Revio system drives sample elasticity ...

What is PacBio's revenue target for 2026?

PacBio continues to target compound annual revenue growth of 40% to 50% through 2026 based on a 2022 revenue base of $128.3 million, representing a 2026 revenue target of over $500 million. PacBio expects to share 2024 guidance on its fourth-quarter earnings conference call in February 2024. About PacBio ...

Will PacBio gain market share in 2025?

"Though challenging, 2024 was a productive year for PacBio as we launched groundbreaking products, strengthened our balance sheet, and made significant progress in reducing cash burn,” said Christian Henry, President and CEO of PacBio. “I believe PacBio is on track to gain market share in 2025 and further enhance our financial position. ...